All articles by Chloe Kent
Chloe Kent
Algae proteins and optogenetics: a vision of the future
The vision of a completely blind man has been partially restored using light-sensing proteins found in algae.
MDIC report explores boosting patient engagement in clinical trials
The US Medical Device Innovation Consortium (MDIC) has published a report on how to improve medical device clinical trials by…
InSilicoTrials: accelerating the uptake of simulation in clinical research
Italian start-up InSilicoTrials is taking advantage of three EU-funded projects to accelerate the uptake of its simulation technology in the development of new medical devices and drugs. What could this could mean for the future of clinical trials?
Indian health ministry fast-tracks drug approvals with new clinical trial legislation
The Indian health ministry has announced that certain drugs approved for use in territories such as the EU and US will be automatically approved in India without a further native clinical trial taking place, in a bid to give patients faster access to new medicines.
DVD previews do not improve clinical trial recruitment, study finds
The inclusion of an audio-visual DVD presentation among study invitation materials does not improve recruitment to clinical trials, a study published in BMC Medical Research Methodology has revealed.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
British universities must improve clinical trial reporting, says House of Commons
The House of Commons Science and Technology Select Committee has announced that UK universities could be brought in for questioning if they fail to improve the transparency of their clinical trial procedure.
Cancer patients with comorbid conditions less likely to enrol in trials
Cancer patients with comorbid disorders are less likely to be offered the opportunity to take part in a clinical trial, according to a study published in JAMA Oncology
EMA publishes revised guidelines on antibacterial drug development
The European Medicines Agency (EMA) has published revised guidelines on the development and evaluation of human medicines intended to treat bacterial infections.